UK markets open in 7 hours 39 minutes
NIKKEI 225
38,073.98 -128.42 (-0.34%) HANG SENG
18,537.81 +223.91 (+1.22%) CRUDE OIL
79.68 +0.42 (+0.53%) GOLD FUTURES
2,354.40 +14.10 (+0.60%) DOW
39,387.76 +331.36 (+0.85%) Bitcoin GBP
50,271.47 +1,580.60 (+3.25%)
BEAM Aug 2024 20.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 01:57PM EDT. Market open.
| Previous close | 4.7500 |
| Open | 4.7500 |
| Bid | 4.3000 |
| Ask | 4.8000 |
| Strike | 20.00 |
| Expiry date | 2024-08-16 |
| Day's range | 4.7500 - 4.7500 |
| Contract range | N/A |
| Volume | |
| Open interest | 45 |
Simply Wall St.Beam Therapeutics Inc. (NASDAQ:BEAM) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
Beam Therapeutics Inc. ( NASDAQ:BEAM ) shareholders are probably feeling a little disappointed, since its shares fell...
ZacksBeam Therapeutics (BEAM) Q1 Loss Narrows, Revenues Miss
Beam Therapeutics (BEAM) reports mixed first-quarter results. The company remains focused on pipeline development.
GlobeNewswireBeam Therapeutics to Participate in RBC Capital Markets 2024 Global Healthcare Conference
CAMBRIDGE, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that John Evans, chief executive officer of Beam, plans to participate in a fireside chat during the RBC Capital Markets 2024 Global Healthcare Conference on Wednesday, May 15, 2024, at 1:35 p.m. ET in New York City. A live webcast will be available in the investor section of the company's website at www.bea
© 2024 Yahoo. All rights reserved.